Expression of Somatostatin Receptor 2 in Somatotropinoma Correlated with the Short-Term Efficacy of Somatostatin Analogues

Figure 2

Correlation between GH (IGF-1 or tumor volume) reduction ratio and the expression of SSTR2 (or SSTR5): (a–c) correlation between the SSTR2 IRS score with GH reduction ratio, IGF-1 reduction ratio or tumor volume reduction ratio, respectively, and (d–f) correlation between SSTR5 IRS score with the same three indexes.

(a)

(b)

(c)

(d)

(e)

(f)